3,000
Participants
Start Date
June 1, 2021
Primary Completion Date
December 31, 2027
Study Completion Date
January 31, 2031
Direct Oral Anticoagulants
choice of DOAC (apixaban, dabigatran, edoxaban or rivaroxaban) according to local practice
RECRUITING
University Hospitals Birmingham, Birmingham
Collaborators (1)
Clinical Practice Research Datalink
OTHER_GOV
University Hospital Birmingham NHS Foundation Trust
OTHER
University of Oxford
OTHER
London School of Economics and Political Science
OTHER
Aston University
OTHER
University of Birmingham
OTHER